A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL
Phase 2 Recruiting
115 enrolled
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Recruiting
200 enrolled
ECP
Recruiting
20 enrolled
FIL_CTCL
Recruiting
400 enrolled
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Phase 2 Recruiting
58 enrolled
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
15,000 enrolled
Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma
Phase 2 Recruiting
34 enrolled
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Phase 1 Recruiting
46 enrolled
Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance
Recruiting
15 enrolled
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Recruiting
100 enrolled
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Recruiting
Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
Phase 2 Recruiting
30 enrolled
Registry of Older Patients With Cancer
Recruiting
3,000 enrolled
A Registry for People With T-cell Lymphoma
Recruiting
1,000 enrolled
BIO-MUSE
Recruiting
120 enrolled
AMITY
Recruiting
100 enrolled